Protocol for the effect evaluation of Individual Placement and Support (IPS): a randomized controlled multicenter trial of IPS versus treatment as usual for patients with moderate to severe mental illness in Norway by Vigdis Sveinsdottir et al.
Sveinsdottir et al. BMC Psychiatry 2014, 14:307
http://www.biomedcentral.com/1471-244X/14/307STUDY PROTOCOL Open AccessProtocol for the effect evaluation of Individual
Placement and Support (IPS): a randomized
controlled multicenter trial of IPS versus treatment
as usual for patients with moderate to severe
mental illness in Norway
Vigdis Sveinsdottir1*, Camilla Løvvik1,4, Tonje Fyhn1, Karin Monstad2, Kari Ludvigsen2, Simon Øverland3,4
and Silje Endresen Reme1Abstract
Background: Roughly one third of disability pensions in Norway are issued for mental and behavioral disorders,
and vocational rehabilitation offered to this group has traditionally been dominated by train-and-place approaches
with assisted or sheltered employment. Based on a more innovative place-and-train approach, Individual Placement
and Support (IPS) involves supported employment in real-life competitive work settings, and has shown great
promise for patients with severe mental illness.
Methods/design: The study is a multicenter Randomized Controlled Trial (RCT) of IPS in a Norwegian context,
involving an effect evaluation, a process evaluation, and a cost/benefit analysis. IPS will be compared to high
quality treatment as usual (TAU), with labor market participation and educational activity at 12 months post
inclusion as the primary outcome. The primary outcome will be measured using register data, and the project will
also include complete follow-up up to 4 years after inclusion for long-term outcome data. Secondary outcomes
include mental health status, disability and quality of life, collected through survey questionnaires at baseline, and
after 6 and 12 months. Participants will include patients undergoing treatment for moderate to severe mental illness
who are either unemployed or on sickness or social benefits. The estimated total sample size of 400–500 will be
randomly assigned to the interventions. To be eligible, participants must have an expressed desire to work, and
sufficient Norwegian reading and writing skills to fill out the questionnaires.
Discussion: The Effect Evaluation of Individual Placement and Support (IPS) will be one of the largest randomized
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evaluate the effectiveness of IPS for patients with moderate to severe mental illness within a Norwegian context.
Trial registration: Clinicaltrials.gov: NCT01964092. Registered October 16th, 2013.
Keywords: Disability, Individual placement and support, IPS, Mental health, Quality of life, Randomized controlled
trial, Vocational rehabilitation, Return to work, Labor market participation, Supported employment* Correspondence: vigdis.sveinsdottir@uni.no
1Uni Research Health, Uni Research, POB 7810, Bergen NO-5020, Norway
Full list of author information is available at the end of the article
© 2014 Sveinsdottir et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Sveinsdottir et al. BMC Psychiatry 2014, 14:307 Page 2 of 10
http://www.biomedcentral.com/1471-244X/14/307Background
Roughly one third of disability pensions in Norway are
issued for mental and behavioral disorders [1]. The
proportion is even higher among those awarded disability
pension before the age of 40, where such disorders ac-
count for 58% of all awards [1]. While approximately
65% of people with severe mental illness want to work,
only 15% are employed, suggesting a large gap of unmet
needs [2]. There are several economic, social, and moral
arguments for facilitating work participation and prevent-
ing exclusion from working life among people suffering
from mental illness, and there is strong evidence suggest-
ing that work can have beneficial effects on physical and
mental health [3,4]. Concerns that competitive employ-
ment could be harmful for patients with severe mental
illness are widespread, but emerging evidence has
shown that work participation improves both clinical
and social functioning, finances, self-esteem, and psychi-
atric symptoms for these patients [5-8]. These observa-
tions can be understood through different models. While
a social selection hypothesis states that good health is
a condition for employment, evidence shows stronger
support for a social causation hypothesis where employ-
ment leads to improved health [4]. Job loss and unemploy-
ment is strongly associated with mental illness, while
re-employment has been shown to reverse the negative
effects of unemployment on mental health [4,9,10]. The
relationship between employment and health may be
partly explained by mechanisms of health behaviors such
as alcohol and substance abuse, diet, physical activity, and
smoking [11-13]. A Norwegian study of alcohol disorders
and re-employment suggested that although some selec-
tion to unemployment does occur, the high prevalence
of harmful drinking among the unemployed is mainly a
result of the unemployment rather than vice versa, and that
reducing unemployment could reduce alcohol problems in
Norway [14].
The Norwegian welfare system provides financial aid
and security for individuals unable to work. It is however
important to optimize the services provided to help people
to remain in working life despite episodes of health prob-
lems or periodical troubles with functioning at work.
Vocational rehabilitation and training approaches gen-
erally fall within two traditions, train and place or place
and train. In the former approach, the client undergoes
targeted training in an adapted or sheltered environment
to acquire necessary skills, before attempting to enter
competitive employment in an arena relevant to the
training. At present, this tradition dominates vocational
rehabilitation in Norway, with programs such as Work with
assistance (AB) and Traineeship in a sheltered business
(APS).
In contrast, the place and train principle represents
a novel approach where the primary goal is directemployment in real-life settings, without any preceding
training. Individual Placement and Support (IPS) is a
prime example of a model within this tradition, where
the goal is to provide professional services to help
people with disabilities participate in the competitive
labor market [15]. The intervention is manualized, and
integrates supported employment as a component of
psychological treatment rather than a separate service.
It focuses on the clients’ preferences, with the philosophy
that anyone who wants to work can find a regular job in
the community, and that no one should be deprived of
that opportunity [16-20]. A further characteristic of the
IPS model is that clients are not screened for work
readiness, but rather on expressed desire to work. It
does not involve intermediate work experiences, tran-
sitional employment or sheltered workshops, but ac-
tively facilitates job acquisition and provides ongoing
support once the client is employed. The model has
got strong empirical support in the American context,
with positive results in terms of both vocational and
non-vocational outcomes for people with severe men-
tal illness [21-29], especially for young adults [30].
There is also favorable evidence for IPS from studies
conducted in European countries, but these have gen-
erally not reached as strong results as the studies from
the US [31-33]. The IPS transportability outside the US
thus remains unanswered [33]. As of yet, no studies
have evaluated the effectiveness of IPS in Norway. The
Norwegian context is characterized by high job secur-
ity, low unemployment, and a generous welfare system,
which stands out from most other contexts where IPS
has been evaluated [34]. Furthermore, previous studies
have all included people with severe mental illness,
with no attempts to expand the target group to involve
people with moderate mental illness as well.
Methods/design
Aims and objectives
The main aim of the study is to evaluate the effect of
IPS compared to high quality TAU offered to people
with moderate to severe mental illness in six IPS centers
located in different Norwegian counties. We aim to ad-
dress the following questions:
– Is IPS more effective than high quality TAU in terms
of increasing labor market participation?
– Is IPS more effective than TAU in terms of
improving mental health status and quality of
life?
– Are there specific Norwegian policy factors that will
influence the effectiveness of IPS?
– What are the challenges of implementing and
disseminating IPS in a Norwegian context?
– Is IPS cost-effective compared to TAU?
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The primary outcome of the study is increased labor
market participation in ordinary paid employment or
education. Employment and enrollment in education
will be identified using register information, and will
be analyzed separately, but also combined as a general
indicator of increased activity on the pathways to work.
Labor market participation will be operationalized by
combining a) being registered in the Norwegian Labor
and Welfare Administrations (NAV) State Register of
Employers and Employees, and b) not receiving un-
employment or sickness benefits, c) not receiving work
assessment allowance or disability pension with a
higher degree of disability than at study inclusion, and
d) a registered annual income. This will align with the
previous IPS literature, where competitive employment
is defined as “permanent jobs paying commensurate
wages in integrated community settings (i.e., employ-
ing nondisabled workers) and available to anyone (not
just individuals with disabilities)” [33]. Educational activ-
ity will be operationalized as started or completed educa-
tion as registered in the Education Statistics by
Statistics Norway (SSB). To ensure comparability of re-
sults with previous IPS-studies [35], we will collect
survey information to supplement the register data re-
garding measures of job acquisition (e.g. time from
study entry to first job start), duration (e.g. cumulative
numbers of weeks worked in all jobs), intensity (e.g. per-
centage working at least 20 hours a week), and productiv-
ity (e.g. total hours worked/wages).
The secondary outcomes, mental health status, disability
and quality of life, will also be measured through survey
questionnaires, in addition to questions on background and
health-related variables:
 Mental Health Status will be measured using the
14-item Hospital Anxiety and Depression Scale
(HADS), consisting of 2 subscales: anxiety (7 items)
and depression (7 items) [36], and the 35-item Beliefs
About Voices Questionnaire-Revised (BAVQ-R),
consisting of 5 subscales: malevolence (6 items),
benevolence (6 items), omnipotence (6 items),
resistance (9 items), and engagement (8 items) [37].
 Disability will be measured using the 12-item version
of the WHO Disability Assessment Schedule 2.0
(WHODAS 2.0), consisting of 6 different functioning
domains: cognition (2 items), mobility (2 items),
self-care (2 items), getting along (2 items), life activities
(2 items), and participation (2 items) [38].
 Health-related quality of life will be measured using
the health index from the EuroQol questionnaire
(EQ-5D) [39].
 Alcohol abuse will be measured using the 3-item
Alcohol Use Disorders Identification Test (AUDIT-C),screening test for heavy drinking and/or active alcohol
abuse or dependence [40].
 Drug abuse will be measured using the Drug Use
Disorders Identification Test (DUDIT), screening for
drug use, drug-related problems, and/or drug
dependence [41].
 Subjective Health Complaints will be measured by
the 29-item Subjective Health Complaints Inventory
(SHC), consisting of 5 subscales: musculoskeletal pain
(8 items), pseudoneurology (7 items), gastrointestinal
problems (7 items), allergy (5 items), and flu
(2 items) [42].
 Social support will be measured using a revised
11-item version of the Social Support Inventory
[43,44] using 2 subscales as suggested by Øyeflaten
et al. [45]: directive social support (4 items) and
nondirective social support (7 items).
 Fatigue will be measured by the 11-item Chalder
Fatigue Questionnaire (CFQ) consisting of 2 subscales:
physical fatigue (7 items) and mental fatigue
(4 items) [46].
The questionnaire package was developed in collabor-
ation with a client representative who provided input on
the length, design and formulation of the information and
questionnaires.
Data collection
Survey data will be collected from both groups at base-
line, 6 and 12 month follow-up. Baseline question-
naires will be administered and collected at the IPS
centers by the person conducting the recruitment in-
terviews. Data will be collected using iPads with secure
survey software (Qualtrics®), but paper questionnaires
will also be available. Electronic data will be collected
in offline mode, before being connected to the Internet
at the IPS center and sent to a secure online database.
Paper questionnaires will be temporarily stored at the
IPS center and forwarded to Uni Research Health every
three months. Follow-up questionnaires will be admin-
istered electronically to participants who provide their
e-mail address at baseline, or on paper via regular mail
if this is preferred.
Using data from the national social insurance register
and the national employee-register in Norway allows for
complete and objective data to be collected every month
for every participant, with no loss to follow-up. Data will
be collected retrospectively 3 years before baseline, and
prospectively 4 years after baseline [47]. This information
will be collected for each month of follow-up, to examine
sensitivity of the primary 12-months results. Additionally,
the long follow-up ensures comparison with a recent
























Figure 1 Sample size calculation with possible rates.
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The project is designed as a randomized controlled trial
(RCT) using mixed methods, and includes: 1) an effect
evaluation, 2) a process evaluation, and 3) a cost/benefit-
analysis.
The effect evaluation is the main focus of the project,
accompanied by a cost/benefit analysis to provide an
economic assessment of the effect. However, in order to
explore different stakeholders’ experiences and various
facilitating factors and barriers in the implementation of
the project, there is also a need for a process evaluation
involving both qualitative and quantitative data.
Effect evaluation
The effect evaluation is conducted as a RCT, which is
the gold standard for clinical trials and ideal for achieving
our aim of comparing the effect of different interventions
to increase labor market participation.
Interventions
Participants will be randomly allocated to one of two
groups, receiving different active interventions that aim
to increase labor market participation and prevent with-
drawal from the labor market. One group will receive
Individual Placement and support (IPS) at their local
IPS center, focusing on employment in the competitive
labor market. IPS is a structured approach based on
eight principles; competitive employment, eligibility based
on client choice, integration of rehabilitation and mental
health services, attention to client preferences, personal-
ized benefits counseling, rapid job search (starting within
one month), systematic job development, and time-
unlimited and individualized support [19]. A pure control
group with no intervention was considered to be neither
feasible nor legally or ethically acceptable in this study.
The other group will therefore be referred from the IPS
center to NAV to receive a high quality version of treat-
ment as usual (TAU). This involves being offered a priori-
tized spot in a vocational rehabilitation scheme, primarily
Work with assistance (AB) and/or Traineeship in a shel-
tered business (APS). AB involves assistance by a personal
facilitator, and includes finding suitable work, negotiating
wage and employment conditions, modified duties, and
follow-up at the work place. APS involves testing of work
capability within a sheltered environment doing tasks that
are modified to individual skills and challenges, with
follow-up as necessary by an advisor. Participants in this
group may also be offered additional interventions based
on the individual needs, as they normally would in TAU.
Participants and recruitment
Eligible participants are patients currently undergoing
treatment for moderate to severe mental illness, who are
currently out of the labor market but have an expresseddesire to work. They could be either unemployed, on
sick leave benefits, or on other social benefits at the time
of inclusion. Participants will primarily be recruited from
the various District Psychiatric Centers (DPS), which are
placed in secondary care, but could also be recruited
from stepped-care initiatives located in primary care. All
participants are or will be connected to a treatment-
team linked to a job specialist (caseworker trained in
IPS). We aim to recruit 200–250 participants in each
group, with a total sample size of 400–500.
Sample size calculation
Our estimates of sample size are based on international
input-data from previous IPS-studies. As a general com-
parison, the typical sample size in the previous IPS studies
range from 41 to 312 participants [33]. The studies from
countries most similar to the Norwegian context include
Australia (n = 41), England (n = 188), the Netherlands
(n = 151), and Sweden (n = 120) [32,33]. For the non-US
studies, the mean competitive employment rate was 50%
for IPS and 20% for controls [33]. The study showing the
lowest effect of IPS to this date came from England, with
competitive employment rates of 22% for IPS and 11% for
controls [48].
If we use 50% and 20% as possible rates, we will need
39 participants in each group in order to demonstrate a
statistically significant difference (with a 5% significance
level and power of 80%), and in a potential scenario with
rates of 22% and 11%, we will need 178 participants in
each group (Figure 1).
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group in the current project is more heterogeneous than
in the international studies, involving people with both
moderate and severe mental illness. Furthermore, we
anticipate that the high quality treatment as usual will
result in higher competitive employment rates in the con-
trol group than in the international studies, particularly
compared to US studies. We therefore aim to recruit
between 400 and 500 participants.
Secondary outcomes are measured with questionnaire
data, and we expect an approximate response rate of no
more than 60%. This may have consequences for the
conclusions drawn from secondary outcome data. How-
ever, compared to a previous IPS study [22] that found a
significant effect on quality of life (mean 5.4, SD = 1.9 vs
4.8, SD = 1.7), the same difference could be detected
with 142 participants in each group with a power of
80%, which in this project should be feasible even with a
response rate of 60%. The analyses of the secondary out-
comes will be performed with inverse probability
weights to account for possible attrition bias [49].
Sufficient inclusion and response rates are crucial for
enabling robust main analyses and for the possibilities to
document effects of IPS with statistical certainty, as well
as for allowing additional subgroup analyses. Rates lower
than the estimated total sample size of 400–500 will re-
duce the chance of detecting smaller effects that may be
important on a larger scale, and will limit the possibilities
to further investigate which groups may benefit most from
the intervention.
Subgroups
Any significant main effects between the IPS intervention
and control intervention group may allow for subgroup
analyses. Regression analyses stratified on intervention
group will additionally be conducted in order to study
variables or sub-groups showing a stronger or weaker
effect. The following a priori defined subgroups will be
investigated: diagnostic groups (moderate vs. severe mental
illness), work status at baseline (unemployed vs. disability
benefits), and previous work history (previously employed
vs. never been employed).
Inclusion and exclusion
Inclusion criteria involved not working (unemployed, on
sick leave, or on social benefits), undergoing treatment
for moderate to severe mental illness, having an expressed
desire to work, and sufficient Norwegian reading and writ-
ing skills to be able to fill out the questionnaires.
Randomization
Upon receiving new eligible participants, trained and
competent personnel at the IPS centers will perform an
introductory interview with the participant, informingabout the study, and asking the individual to fill out an
informed consent form in order to be included in the
study and receive an ID-number. When the participant
has filled out the baseline-questionnaires, the person
conducting the introductory interview contacts the re-
search technician at Uni Research Health by email, stating
the participants ID-number, gender, and year of birth.
Using computer-generated randomization lists, the par-
ticipant will be allocated to one of the two groups. A 2:1
randomization ratio will be applied the first months of
recruitment to ensure that the IPS centers can run accord-
ing to capacity. The randomization procedure will however
strictly adhere to the formal requirements of adequate
randomization at all times.
Statistical analyses
The analyses will follow the “intention to treat” principle.
We will apply administrative register data from NAV and
SSB in order to evaluate the primary outcome of the pro-
ject; labor market participation in ordinary paid employ-
ment and educational activity. Beyond giving consent at
inclusion, this part of the effect evaluation is not
dependent upon participants’ willingness to respond to
surveys, as register data on employment, education and
use of social security benefits will be complete for all
participants. Consequently, common problems related to
self-report such as recall bias, justification bias, and
attrition will be avoided for our primary outcomes.
Randomization helps to assure that there are no systematic
differences between the IPS intervention and control interven-
tion groups at baseline, in terms of both observable and unob-
servable characteristics. The design allows for a comparison of
proportions employed in each group over time before and
after inclusion, including a test of whether differences are sta-
tistically significant. Additionally, we will perform regression
analysis using logistic regression models in order to a) control
for any remaining variation in observable characteristics be-
tween groups, b) investigate which factors, other than IPS
intervention, have an impact on labor market participation,
and c) analyze heterogeneity in the response to IPS. Groups
will be compared on secondary outcome measures using sur-
vey data at baseline, and after 6 and 12 months.
Process evaluation
The purpose of the process evaluation is to investigate
the quality and accuracy of the implementation of the
IPS intervention. Furthermore, the results of a process
evaluation may provide indications for weaknesses either
in the implementation of the program, or theoretical
weaknesses, in case of unexpected findings in the effect
evaluation. Investigating the implementation of key com-
ponents of the intervention will provide context for the
interpretation of main results, as well as highlight any
need for improvements in future intervention design,
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tion. Together, the results of process investigation will
help to determine the feasibility of the intervention.
Following the framework of Steckler & Linnan [50], sup-
plemented by the broader process evaluation literature of
Baranowski & Stables [51] and Green & Glasgow [52], the
process evaluation will report on the following:
– Reach, referring to the participation rate of the
target group and the representativeness of these
[52], which affects the external validity of the study.
– Dose delivered, which refers to the amount of the
intended intervention that is actually offered to the
participants [50].
– Dose received may refer to the applicant’s use of
teaching material, conducting home assignments or
attending meetings [50].
– Fidelity refers to the providers’ compliance with the
IPS protocol, which is a standardized measurement
[53]. The fidelity ratings are conducted regularly
throughout the project period.
– Satisfaction refers to the participants’ overall
satisfaction with the program.
– Perceived effectiveness is the participants’ perception
of the usefulness of IPS in obtaining employment.
– Facilitators and barriers will shed light on
methodological or practical issues as well as factors
in the local context that helps or hinders the
implementation of the intervention.
The process evaluation will take place alongside the
project implementation, and data will be collected through-
out the project period in order to monitor how the
intervention is established and adapted over time.
Quantitative material
The process evaluation includes collecting quantitative
data that can describe how the different elements of
the intervention were implemented. This information
will be important in order to identify possible meth-
odological challenges at the individual IPS centers, as
expressed by the measures in the above framework:
Reach, dose delivered and received, and fidelity. To ex-
plore local barriers towards successful implementation,
we will also measure employers’ attitudes to hiring
people who are at risk of being excluded from work
life, as well as review characteristics of the local labor
market.
1. Questionnaire items at 6-month follow-up: 6–8
items will be included in the questionnaire at
6 months, measuring dose received, satisfaction,
perceived efficacy, and perceived barriers and
facilitators. The items are constructed based onprocess evaluation theory and adapted to the
conditions of the current intervention.
2. Other data sources: To determine the dose given,
data will be collected from the job specialists’ register
for each participant. To determine reach, the job
specialists’ register of people who declined or accepted
participation will be used. Publicly available statistical
data will be used to examine the representativeness of
the reached group in relation to the target group at
large, using the variables age and gender.
3. Fidelity measurements: The IPS fidelity scale is an
established measurement [53], and the ratings will
be carried out by a partly independent team that is
trained, certified, and experienced in making such
measurements. The measurements will be
performed regularly throughout the project period.
The fidelity ratings will evaluate the competence and
methodology in conducting the intervention, as well
as provide information on the frequency of contact
and interaction with the participants. The qualitative
interviews included in the fidelity measurements will
provide a greater understanding and description of
how the criteria have been attained, or why they
may not have been attained. Although the process
evaluation largely focuses on the IPS intervention
group, qualitative interviews will also be conducted
with participants in the control intervention group
to get an idea of what control measures the ordinary
follow-up has consisted of.
4. Questionnaire for employers: The quality of the
relationship between employer and employee can play
an important role for commitment to the work place,
job performance, and job satisfaction [54,55]. In order
to examine attitudes towards hiring employees with
various physical or mental illnesses and/or other
limitations, researchers in the project group have
developed a questionnaire that will be distributed to
employers. In addition to providing a general overview
of attitudes towards groups at risk of discrimination,
we may also examine if any changes in attitudes occur
after hiring employees with various challenges.
5. Local labor market: The local labor market is likely
to vary between the centers’ catchment areas, and
availability of work can influence on the outcomes.
Characteristics of the local labor market will
therefore be controlled for, mainly by using county
indicators such as structure and size of trade and
industry, travel distances, unemployment rate
according to gender and age group, and
unemployment rate to vacant positions ratio.
Qualitative material
Firstly, the qualitative analysis will be based upon the
key documents that form the basis for the planning,
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policy documents, formal agreements, plans for the IPS
centers, and reports from the organization. The document
analysis will be an important part of the initial phase of
the project, in order to establish an overview of the formal
organization, background, and adaptation of the IPS-
intervention. Reports will be collected and analyzed to-
wards the end of the project period, to retain additional
information of adaptations and alterations.
Secondly, semi-structured interviews with key inform-
ant groups will be conducted. Through the interviews,
we will elaborate on the experiences of key persons and
their views on barriers and facilitators in carrying out
the implementation. Interviews with the various stake-
holders will also help to identify the extent of cross-
sectorial collaboration between NAV, specialist- and
primary care, and its development throughout the project
period. The following interviews will be conducted:
1. Phone interview with key informants in NAV and
the health services, regarding planning,
management, and operation of IPS at central and
county levels. This will be carried out in the first
phase of the project, in order to get a broader idea
of the background and foundation of the
intervention and the main features at the initial
phase. Scope: 5–8 informants. Time: Fall 2014.
2. Focus groups consisting of staff and management
from all IPS centers. We choose to utilize focus
group interviews as a method, as they provide an
efficient collection of qualitative data [56]. The
strength of focus group approach is also that the
form allows for the exchange of experiences in
dialogue with others. Time: Fall 2014.
3. Follow-up phone-interviews with the management
of the IPS centers. The aim is to obtain information
about local adaptations and adjustments, as well as
specific challenges and barriers that have arisen in
the IPS centers during the implementation. Scope: 3
informants. Time: Spring 2015.
4. Phone interview with collaborators in NAV and
DPS. This will help to identify how intersectoral
collaboration has worked, and barriers and
facilitators in this area. We will go in depth on
cooperative relations between 2–3 selected IPS
centers with different target groups of participants.
Scope: 10–15 informants. Time: Spring 2015.
5. In-depth interviews with participants. The qualitative
material will include in-depth interviews with
participants, in order to explore their experiences
more elaborately. We will perform a purposeful
sampling based on relevant characteristics of the
target group combined with the responses to the
questionnaires. The method of purposefulsampling is chosen in order to get insight into the
heterogeneity rather than the frequency of perceived
barriers. In-depth interviews will be conducted with
participants giving positive versus negative evaluations
in the questionnaire. Scope: 12 to 15 informants.
Time: Fall 2014.
The 6-month follow-up questionnaires sent to the IPS
intervention group will also include a separate set of
open-ended questions about the experiences of the inter-
vention, such as accessibility, coordination, and attitudes
of service providers, which will be analyzed as part of the
qualitative process evaluation.
Cost/benefit analysis
The third component of the project is an economic as-
sessment of effect as compared to the resources spent
on the intervention. IPS is offered in the public sector
and financed by community resources, and a standard
approach for assessing the profitability of public projects
will be used [57].
The cost-benefit analysis will be based on the effect
that the intervention has on labor market participation,
and the effect that the intervention has on mental
health/disability. In the first case, we calculate the eco-
nomic benefit (measured in Norwegian Kroner, NOK) as
a result of the employment effect of the intervention.
The calculation compares income and costs of the IPS
intervention with income and costs of the control inter-
vention (TAU with AB or APS). In the second case,
where the outcome goal represents health benefits as
measured by functional improvement or improved qual-
ity of life, the costs of the intervention is seen in terms
of health gains achieved. Effect may be compared to
costs related to different interventions with the same
purpose, in order to analyze which intervention provides
the greatest health benefit per NOK. Using standardized
conversion tools it is also possible to convert health
benefits of the interventions to an index of health-
related quality of life. This type of analysis also allows
for a comparison of gain in quality of life across the
different interventions.
The project aims to identify the economic cost and
benefit of IPS, in addition to monitoring cost and benefit
related to the TAU for the participants in the control
intervention group, primarily AB and APS. Both in IPS
and AB/APS, income constitutes the present value of
the future production gains due to the participants being
employed rather than receiving social security benefits.
This must be seen in relation to the cost of the respective
interventions. We will use a societal perspective, taking
into account that the measures affect government bud-
gets, and tax financing influences the adaptation of private
actors. We will also take into account that the participants
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seeking out specialist in psychiatry in the follow-up period
compared to the control intervention group, and we will
estimate the costs of such treatment. An observation win-
dow of 18 months after inclusion will be used as a basis to
assess the extent of treatment/follow-up in the two groups.
The main source of information is register data from
NAV and the Norwegian Patient Register. Estimates for
the costs associated with different types of treatment
must then be calculated based on information about
what different types of treatment/services cost, such as
appointments with psychiatric specialists or hospitalization
days at a psychiatric institution. This must be based both
on information about operating expenses at the IPS centers,
and pricing of other relevant services within and outside of
NAV.
In order to calculate the cost of IPS, we need informa-
tion on both fixed and variable operating expenses. How
this is to be recorded during the project period, for ex-
ample, if costs are to be registered on the individual level
or, as an average per participant based on the annual total
expenditure of the IPS centers, will be finalized when this
information is available. Since the cost component in the
calculations primarily should include additional costs of
IPS, costs that would otherwise be incurred in TAU
should be subtracted. The details of this must be decided
in consultation with NAV and the IPS centers.
Ethical considerations
The project was submitted to the Norwegian Regional
Ethical Committee and therefrom referred to the
Norwegian Social Science Data Services, who approved
the study (project number: 34989). All principles in the
Helsinki declaration will be followed, personal confi-
dentiality is guaranteed, and declarations of voluntary
participation with detailed information on the processes
will be signed by each participant upon inclusion. The
declaration of informed consent emphasizes the right to
withdraw from the project at any time without any ex-
planation. We consider the randomization procedure to
be ethically acceptable, and so do our collaborators in
NAV. The project is registered in the international trial
register ClinicalTrials.gov (NCT01964092).
Conclusion
The effect evaluation of Individual Placement and Support
(IPS) is a large and comprehensive project, providing
evidence-based information on the important issue of re-
habilitating patients who are currently out of the labor
market. It will be the first RCT to evaluate the effective-
ness of IPS for patients with moderate to severe mental ill-
ness within a Norwegian context, and one of the largest
RCTs to date investigating the effect of IPS on competitive
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